Milestone Scientific (MLSS) Stock Price, News & Analysis

Company Overview

Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

Key Stats

• Today's Range: $0.88 to $0.90
• 50-Day Range: $0.88 to $1.09
• 52-Week Range: $0.58 to $1.39
• Volume: 60,581 shs
• Average Volume: 129,970 shs
• Market Capitalization: $69.06 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $1.25
• Consensus Rating: Buy

Milestone Scientific Stock Analysis - MarketRank™

Milestone Scientific scored higher than 45% of companies evaluated by MarketBeat, and ranked 650th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Milestone Scientific has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Milestone Scientific has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Milestone Scientific is -12.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Milestone Scientific is -12.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Milestone Scientific has a P/B Ratio of 8.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.31% of the float of Milestone Scientific has been sold short.

Short Interest Ratio / Days to Cover

Milestone Scientific has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Milestone Scientific has recently increased by 42.46%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Milestone Scientific does not currently pay a dividend.

Dividend Growth

Milestone Scientific does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.31% of the float of Milestone Scientific has been sold short.

Short Interest Ratio / Days to Cover

Milestone Scientific has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Milestone Scientific has recently increased by 42.46%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 1.6 / 5
• News Sentiment: -0.04

News Sentiment

Milestone Scientific has a news sentiment score of -0.04. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.88 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for Milestone Scientific this week, compared to 1 article on an average week.

MarketBeat Follows

1 people have added Milestone Scientific to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Milestone Scientific insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $95,530.00 in company stock.

Percentage Held by Insiders

24.75% of the stock of Milestone Scientific is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 5.79% of the stock of Milestone Scientific is held by institutions.

MLSS Stock Analysis - Frequently Asked Questions

How have MLSS shares performed this year?

Milestone Scientific's stock was trading at $0.96 at the beginning of the year. Since then, MLSS shares have decreased by 8.3% and is now trading at $0.88.
View the best growth stocks for 2025 here.

How were Milestone Scientific's earnings last quarter?

Milestone Scientific Inc. (NYSE:MLSS) posted its quarterly earnings results on Thursday, August, 15th. The company reported ($0.02) earnings per share for the quarter, missing analysts' consensus estimates of ($0.01) by $0.01. The business had revenue of $1.85 million for the quarter. Milestone Scientific had a negative trailing twelve-month return on equity of 60.26% and a negative net margin of 52.01%.

Who are Milestone Scientific's major shareholders?

Milestone Scientific's top institutional investors include Brookwood Investment Group LLC (0.06%) and XTX Topco Ltd (0.04%). Insiders that own company stock include SRL Bp4, Leonard Osser, Neal I Goldman, Michael Mcgeehan and Leslie Bernhard.
View institutional ownership trends.

How do I buy shares of Milestone Scientific?

Shares of MLSS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Milestone Scientific own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Milestone Scientific investors own include Waste Connections (WCN), DiamondRock Hospitality (DRH), The RMR Group (RMR), AUO (AUOTY), iShares Micro-Cap ETF (IWC), American Water Works (AWK) and Triple Flag Precious Metals (TFPM).

Company Calendar

• Last Earnings: 8/15/2024
• Today: 6/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Surgical appliances & supplies
• Sub-Industry: Medical Equipment
• Current Symbol: NYSE:MLSS
• CIK: 855683
• Web: www.milestonescientific.com
• Phone: (973) 535-2717
• Fax: 973-535-2829
• Employees: 30
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $1.25
• High Stock Price Target: $1.25
• Low Stock Price Target: $1.25
• Potential Upside/Downside: +42.0%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($0.07)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$6.93 million
• Net Margins: -52.01%
• Pretax Margin: -52.21%
• Return on Equity: -60.26%
• Return on Assets: -40.23%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.85
• Quick Ratio: 1.86

Sales & Book Value

• Annual Sales: $8.61 million
• Price / Sales: 8.02
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.11 per share
• Price / Book: 8.00

Miscellaneous

• Outstanding Shares: 78,477,000
• Free Float: 58,614,000
• Market Cap: $69.06 million
• Optionable: Optionable
• Beta: 0.90